Continence recovery after robotic-assisted radical Retzius-sparing prostatectomy
Objective. To assess time to urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) and to describe early perioperative and oncological outcomes.Mammaev R.U., Safiullin R.I., Shatylko T.V., Gamidov S.I., Rodin I.M., Myagkova V.D., Popova A.Y.
Materials and methods. A retrospective analysis was performed of patients who underwent RS-RARP in 2022–2024. The primary endpoint was time to complete urinary continence (0 pads/day). Time-to-event analysis (continence recovery) was carried out using the Kaplan–Meier method, with cumulative event probability visualized as (1−S(t)) and 95% confidence intervals calculated.
Results. A total of 344 patients were included. On day 1 after urethral catheter removal, complete continence was observed in 90,1% of patients (0–1 pad/day in 97,3%). Complete continence rates were 92,1% at 1 month and 97,2% at 12 months. Mean time to continence recovery was 0,7 months (95% CI 0,428–0,973). Positive surgical margins were detected in 9% of cases; no biochemical recurrence was recorded during follow-up. Mean operative time was 113 min and mean blood loss was 121 mL.
Conclusions. RS-RARP provides rapid recovery of urinary continence with high early complete continence rates and acceptable perioperative and short-term oncological outcomes. Comparative studies versus standard RARP and comprehensive analyses of oncological and functional outcomes are needed to further clarify the advantages and limitations of this technique.
Keywords
prostate cancer
robot-assisted radical prostatectomy
Retzius-sparing
urinary continence
urinary incontinence



